This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Conclusion
To eliminate cancer differences in Latino populations, Advancing the Science of Cancer in Latinos brought together researchers, scientists, physicians, healthcare professionals, patient advocates, and students from across the US and Latin America. These presenters shared research advancements, identified gaps, developed actionable goals, updated clinical best practices, described effective community interventions, and detailed professional training programs aimed at addressing differences. In the process, most of the speakers made ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Using Science to Address Latino Health Inconsistencies in Research
Eliseo J. Pérez-Stable, M.D., is Director of the NIMHD at the National Institutes of Health (NIH). Health Differences and Non-Medical Drivers of Health Dr. Pérez-Stable began his presentation by discussing the ways in which science can reduce differences in healthcare. First, standardized surveys, tools, and measurements are needed so that data can be combined, facilitating discovery through large data sets. Science should also be an engine for promoting variety in ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Transformative Strategies in Science and Access in the US
Dr. Edith A. Perez is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic College of Medicine and the Chief Medical Officer at Bolt Biotherapeutics. Her presentation outlined strategies for health improvement as exemplified by important committees of the National Academies of Sciences, Engineering, and Medicine (NASEM) and Stand Up To Cancer (SU2C). The NASEM initiative, which was requested by congress, focuses on improving the reflectivity of people in ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Updates in Genomics of Breast Cancer among Latina Women
Dr. Elad Ziv is a Professor of Medicine at the University of California San Francisco (UCSF), with a research focus on human genetics of cancer susceptibility and hematological traits. Genomics Explained To set the stage for his presentation, Dr. Ziv explained genomics in a lay-friendly way, describing it as a long series of letters. A change of one letter in this series, from an A to a G for example, can lead to anything from a change in height to a disease susceptibility. Not ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Addressing Differences to Advance Health Improvement for Latinos
Dr. Marcella Nunez-Smith is an internal medicine physician, the Associate Dean for Health [Improvement] Research at Yale School of Medicine, and the Associate Director for Community Outreach and Engagement at the Cancer Center. Dr. Nunez-Smith served as chair of the Presidential COVID-19 Health [Improvement] Task Force, and is one of the nation's foremost experts on differences in healthcare access. Health Differences Affecting Neglected Communities Dr. Nunez-Smith spoke ...
This is part of the "Advancing the Science of Cancer in Latinos: 2022 Conference Proceedings," which summarizes findings and discussions of the 2022 Advancing the Science of Cancer in Latinos Conference on Feb. 23-25, 2022, in San Antonio, Texas.
Healthcare Improvement in the Latino community
The United States healthcare system is rife with challenges affecting the Latino community, with a population of 60.6 million [Estrada]. Health challenges include higher rates of infant mortality, stroke, cancer, heart disease, diabetes, hypertension, and COVID-19. [Webb Hooper, Duma] Latino patients, especially those who are uncomfortable discussing care in English, are often labeled as unintelligent and non-compliant. [Duma] In the COVID-19 pandemic, cases among the Latino population have been ...
Consuming cold-water fish and other sources of omega-3 fatty acids could preserve brain health and enhance cognition in middle age, according to a recent study led by researchers at UT Health San Antonio and the Framingham Heart Study. “Our results, albeit exploratory, suggest that higher omega-3 fatty acid concentrations are related to better brain structure and cognitive function in a predominantly middle-aged cohort free of clinical dementia,” according to the study.
What Are Omega-3s?
Omega-3s are a family of essential fatty acids that play an important role in the human body. “Although evidence is mixed, studies indicate that omega-3 fatty acids can protect against all sorts of illnesses, including breast cancer, depression, ADHD, and various inflammatory diseases,” ...
U.S. Latinos face heavier burdens of stomach, liver, and cervical cancers, and worse outcomes for many cancers, than their White peers. But why? Unfortunately, many factors cause these disparities, from poverty and a lack of healthcare access to cultural barriers, acculturation, and genetic heritage. That's why it takes everyone working together to address Latino cancer. To this end, UT Health San Antonio has published a new open-access book, Advancing the Science of Cancer in Latinos: Building Collaboration for Action. The book is a collection of articles based on presentations at the 2nd biennial Advancing the Science of Cancer in Latinos conference on Feb. 26-28, 2020, in San Antonio, co-hosted by Mays Cancer Center and the Institute for Health Promotion Research (IHPR) ...
Rapamycin is a medication approved by the US Food and Drug Administration as an immunosuppressant drug, making it helpful in preventing rejection in organ transplantation. The medication has also been tested in prior studies — like clinical trials, which help researchers learn how to better slow, manage, and treat diseases — as a treatment for cancer and to evaluate its effects on physical and cognitive function and immune health. Now, researchers at UT Health San Antonio are recruiting participants for a study to evaluate Rapamycin’s effects on heart function, heart muscle stiffening, and circulation. Participants will be compensated up to $300 for study completion, which involves five study visits over the course of about two months.
Who Can Participate in the Rapamycin ...
